Enhanc3D Genomics is a functional genomics company exploring the 3D organisation of DNA in health and disease. The company leverages its GenLink3D platform to identify new biomarkers and novel treatment targets for cancer, ageing, and autoimmune conditions.

Enhanc3D Genomics

CSM provides tools for converting images, text, or sketches into 3D models and environments. The service aims to accelerate 3D production workflows, reducing the time and cost associated with creating 3D assets.

Sloyd is an AI-driven design platform that enables users to create and customize 3D models for various applications, including gaming, VR, and AR. The platform leverages machine learning to simplify the design process, making it accessible to both professionals and hobbyists.

Metric
Company Name	Enhanc3D Genomics	CSM	Sloyd
Symbol
MSH ID	COM:ENHANC3DGENOMICS	AI:CSM	AI:SLOYD
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Technology
Industry	Biotechnology	Software Development	Technology
Country	GB	US	NO
Stage
Employee Count			15
Website	enhanc3dgenomics.com	csm.ai	sloyd.ai
LinkedIn			sloyd
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score			10.36
28-Day Growth Score			16.39
90-Day Growth Score			14.09
365-Day Growth Score			13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ENHANC3DGENOMICS

Enhanc3D Genomics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue